Skip to main content

Advertisement

SpringerLink
Log in

Methicillin-resistant Staphylococcus aureus bacteraemia and mortality in a teaching hospital

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is responsible for more than 40% of S. aureus bacteraemias in the UK and is associated with considerable morbidity and mortality. This retrospective audit examined the epidemiology of MRSA bacteraemia (MRSAB) at our institution, where the MRSAB rate has been high. A retrospective case note review was undertaken of all patients dying within 90 days of an episode of MRSAB during a 12-month period. A clinical panel classified deaths as having MRSAB as the main cause, contributing cause or having no bearing on the death. Sixty-two patients had one or more episodes of MRSAB and 30 died within 90 days. The mean age of those dying was 72 (43–96) years and of those surviving was 57 (21–87) years. MRSAB was judged to be the main or contributing cause of death in 24 cases, giving an associated mortality of 39%. All-cause mortality at 7, 30 and 90 days was 19, 40 and 48%, respectively. We investigated the minimum inhibitory contribution (MIC) to vancomycin for 79 MRSAB isolates, of which 70.8% of isolates had an MIC value of 2 mg/l. None of the isolates expressed heteroresistance to vancomycin. Five out of seven patients in whom MRSAB was the main cause of death had community onset of infection. It is unlikely that efforts to reduce delays in delivering effective antimicrobial therapy will have a major impact on mortality. Efforts to reduce the burden of MRSAB should focus on the primary prevention of bacteraemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Johnson AP, Pearson A, Duckworth G (2005) Surveillance and epidemiology of MRSA bacteraemia in the UK. J Antimicrob Chemother 56(3):455–462, doi:10.1093/jac/dki266

    Article  PubMed  CAS  Google Scholar 

  2. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36(1):53–59, doi:10.1086/345476

    Article  PubMed  Google Scholar 

  3. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y (2005) The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 26(2):166–174, doi:10.1086/502522

    Article  PubMed  Google Scholar 

  4. Moise PA, Sakoulas G, Forrest A, Schentag JJ (2007) Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 51(7):2582–2586, doi:10.1128/AAC.00939-06

    Article  PubMed  CAS  Google Scholar 

  5. Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC Jr, Eliopoulos GM (2004) Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 42(6):2398–2402, doi:10.1128/JCM.42.6.2398-2402.2004

    Article  PubMed  CAS  Google Scholar 

  6. Chief Medical Officer. Surveillance of Healthcare Associated Infections. CMO Letter PL/CMO/2003/4, PL/CNO/2003/4. London: Department of Health, 9 June 2003

  7. Andrews JM (2001) Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48(Suppl 1):5–16

    PubMed  CAS  Google Scholar 

  8. Walsh TR, Bolmström A, Qwärnström A, Ho P, Wootton M, Howe RA et al (2001) Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol 39:2439–2444, doi:10.1128/JCM.39.7.2439-2444.2001

    Article  PubMed  CAS  Google Scholar 

  9. Wilson APR, Hayman S, Cepeda JA, Singer M, Bellingan G (2006) Screening for MRSA and GISA in the intensive care unit. J Hosp Infect 64:85–94, doi:10.1016/j.jhin.2006.05.003

    Article  PubMed  CAS  Google Scholar 

  10. [No authors listed] (1995) Epidemic methicillin resistant Staphylococcus aureus. Commun Dis Rep 351(5)

  11. Coello R, Glynn JR, Gaspar C, Picazo JJ, Fereres J (1997) Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect 37(1):39–46, doi:10.1016/S0195-6701(97)90071-2

    Article  PubMed  CAS  Google Scholar 

  12. Asensio A, Guerrero A, Quereda C, Lizán M, Martinez-Ferrer M (1996) Colonization and infection with methicillin-resistant Staphylococcus aureus: associated factors and eradication. Infect Control Hosp Epidemiol 17(1):20–28

    Article  PubMed  CAS  Google Scholar 

  13. Chang FY, MacDonald BB, Peacock JE Jr, Musher DM, Triplett P, Mylotte JM et al (2003) A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) 82(5):322–332, doi:10.1097/01.md.0000091185.93122.40

    Article  Google Scholar 

  14. Lin JC, Yeh KM, Peng MY, Chang FY (2004) Community-acquired methicillin-resistant Staphylococcus aureus bacteremia in Taiwan: risk factors for acquisition, clinical features and outcome. J Microbiol Immunol Infect 37(1):24–28

    PubMed  Google Scholar 

  15. Mylotte JM, Tayara A (2000) Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 31(5):1170–1174, doi:10.1086/317421

    Article  PubMed  CAS  Google Scholar 

  16. Kaech C, Elzi L, Sendi P, Frei R, Laifer G, Bassetti S et al (2006) Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. Clin Microbiol Infect 12(4):345–352, doi:10.1111/j.1469-0691.2005.01359.x

    Article  PubMed  CAS  Google Scholar 

  17. Lodise TP, McKinnon PS, Swiderski L, Rybak MJ (2003) Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 36(11):1418–1423, doi:10.1086/375057

    Article  PubMed  Google Scholar 

  18. Guilarde AO, Turchi MD, Martelli CM, Primo MG (2006) Staphylococcus aureus bacteraemia: incidence, risk factors and predictors for death in a Brazilian teaching hospital. J Hosp Infect 63(3):330–336, doi:10.1016/j.jhin.2006.02.011

    Article  PubMed  CAS  Google Scholar 

  19. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118(1):146–155, doi:10.1378/chest.118.1.146

    Article  PubMed  CAS  Google Scholar 

  20. Kim SH, Park WB, Lee KD, Kang CI, Bang JW, Kim HB et al (2004) Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 54(2):489–497, doi:10.1093/jac/dkh366

    Article  PubMed  CAS  Google Scholar 

  21. Roghmann MC (2000) Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia. Arch Intern Med 160(7):1001–1004, doi:10.1001/archinte.160.7.1001

    Article  PubMed  CAS  Google Scholar 

  22. Fang CT, Shau WY, Hsueh PR, Chen YC, Wang JT, Hung CC et al (2006) Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome. J Antimicrob Chemother 57(3):511–519, doi:10.1093/jac/dkl006

    Article  PubMed  CAS  Google Scholar 

  23. Khatib R, Saeed S, Sharma M, Riederer K, Fakih MG, Johnson LB (2006) Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 25(3):181–185, doi:10.1007/s10096-006-0096-0

    Article  PubMed  CAS  Google Scholar 

  24. Maclayton DO, Suda KJ, Coval KA, York CB, Garey KW (2006) Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis. Clin Ther 28(8):1208–1216, doi:10.1016/j.clinthera.2006.08.003

    Article  PubMed  CAS  Google Scholar 

  25. Moise PA, Smyth DS, El-Fawal N, Robinson DA, Holden PN, Forrest A et al (2008) Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 61(1):85–90, doi:10.1093/jac/dkm445

    Article  PubMed  CAS  Google Scholar 

  26. Johnson AP, Aucken HM, Cavendish S, Ganner M, Wale MCJ, Warner M, UK EARSS participants et al (2001) Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS). J Antimicrob Chemother 48:143–144, doi:10.1093/jac/48.1.143

    Article  PubMed  CAS  Google Scholar 

  27. Selvey LA, Whitby M, Johnson B (2000) Nosocomial methicillin-resistant Staphylococcus aureus bacteremia: is it any worse than nosocomial methicillin-sensitive Staphylococcus aureus bacteremia? Infect Control Hosp Epidemiol 21(10):645–648, doi:10.1086/501707

    Article  PubMed  CAS  Google Scholar 

  28. Soriano A, Martínez JA, Mensa J, Marco F, Almela M, Moreno-Martínez A et al (2000) Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 30(2):368–373, doi:10.1086/313650

    Article  PubMed  CAS  Google Scholar 

  29. Lodise TP, McKinnon PS (2005) Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis 52(2):113–122, doi:10.1016/j.diagmicrobio.2005.02.007

    Article  PubMed  Google Scholar 

  30. de Oliveira Conterno L, Wey SB, Castelo A (2002) Staphylococcus aureus bacteremia: comparison of two periods and a predictive model of mortality. Braz J Infect Dis 6(6):288–297, doi:10.1590/S1413-86702002000600004

    PubMed  Google Scholar 

  31. Talon D, Woronoff-Lemsi MC, Limat S, Bertrand X, Chatillon M, Gil H et al (2002) The impact of resistance to methicillin in Staphylococcus aureus bacteremia on mortality. Eur J Intern Med 13(1):31–36, doi:10.1016/S0953-6205(01)00189-3

    Article  PubMed  CAS  Google Scholar 

  32. Das I, O’Connell N, Lambert P (2007) Epidemiology, clinical and laboratory characteristics of Staphylococcus aureus bacteraemia in a university hospital in UK. J Hosp Infect 65(2):117–123, doi:10.1016/j.jhin.2006.09.022

    Article  PubMed  CAS  Google Scholar 

  33. Shurland S, Zhan M, Bradham DD, Roghmann MC (2007) Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol 28(3):273–279, doi:10.1086/512627

    Article  PubMed  Google Scholar 

  34. Karas JA, Enoch DA, Emery MM (2006) Community-onset healthcare-associated MRSA bacteraemia in a district general hospital. J Hosp Infect 62(4):480–486, doi:10.1016/j.jhin.2005.10.001

    Article  PubMed  CAS  Google Scholar 

  35. Wyllie DH, Crook DW, Peto TE (2006) Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997–2003: cohort study. BMJ 333(7562):281, doi:10.1136/bmj.38834.421713.2F

    Article  PubMed  Google Scholar 

  36. Melzer M, Eykyn SJ, Gransden WR, Chinn S (2003) Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis 37(11):1453–1460, doi:10.1086/379321

    Article  PubMed  CAS  Google Scholar 

  37. Osmon S, Ward S, Fraser VJ, Kollef MH (2004) Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa. Chest 125(2):607–616, doi:10.1378/chest.125.2.607

    Article  PubMed  Google Scholar 

  38. Gemmell CG, Edwards DI, Fraise AP, Gould FK, Ridgway GL, Warren RE (2006) Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother 57(4):589–608, doi:10.1093/jac/dkl017

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

A summary of this work was presented as a poster at the Federation of Infection Societies, Cardiff, UK, November 2006. We wish to thank Angela Kearns at the Centre for Infections, London, for her advice on phenotyping isolates.

Author information

Authors and Affiliations

  1. Microbiology Department, Salford Royal NHS Foundation Trust, Salford, M6 8HD, UK

    C. J. Beeston, R. Gupta, P. R. Chadwick & P. R. Chadwick

  2. Diabetes and Endocrinology, Salford Royal NHS Foundation Trust, Salford, M6 8HD, UK

    R. J. Young

Authors
  1. C. J. Beeston
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. R. Chadwick
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. J. Young
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. R. Chadwick.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beeston, C.J., Gupta, R., Chadwick, P.R. et al. Methicillin-resistant Staphylococcus aureus bacteraemia and mortality in a teaching hospital. Eur J Clin Microbiol Infect Dis 28, 585–590 (2009). https://doi.org/10.1007/s10096-008-0675-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-008-0675-3

Keywords

Search

Navigation